Shares of Novavax (NASDAQ: NVAX) are down more than 13% today after the U.S. Food and Drug Administration (FDA) released ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE